{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:10:19Z","timestamp":1758579019454,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.transproceed.2023.02.067","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T01:01:23Z","timestamp":1688518883000},"page":"1551-1554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-8709","authenticated-orcid":false,"given":"Ahmet Ziya","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Usalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih Mehmet","family":"Erdur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celalettin","family":"Usalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.02.067_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2015.2","article-title":"United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease","volume":"5","author":"Collins","year":"2015","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0002","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1097\/MJT.0000000000000150","article-title":"Tacrolimus versus cyclosporine as primary immunosuppressant after renal transplantation: a meta-analysis and economics evaluation","volume":"23","author":"Liu","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2015.190","article-title":"Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation","volume":"88","author":"Wu","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0004","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/nep.12728","article-title":"BK virus nephropathy in renal transplant recipients","volume":"21","author":"Jamboti","year":"2016","journal-title":"Nephrology"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0006","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1399-0012.2003.00102.x","article-title":"Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy","volume":"17","author":"B\u00fcchler","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0007","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/jcm9051320","article-title":"Outcome comparison between low-dose rabbit anti-thymocyte globulin and basiliximab in low-risk living donor kidney transplantation","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0008","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/bmt.2017.100","article-title":"Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia","volume":"52","author":"Zhang","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S2095-4964(17)60314-5","article-title":"The combination of anti-thymocyte globulin and basiliximab for haploidentical hematopoietic stem cell transplantation","volume":"8","author":"Wang","year":"2017","journal-title":"Integr J Med"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0011","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0012","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.transproceed.2018.02.088","article-title":"Thymoglobulin versus basiliximab induction therapy in low-risk kidney transplant recipients: a single-center experience","volume":"50","author":"Lee","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0013","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10157-017-1480-z","article-title":"Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0014","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1097\/TXD.0000000000001190","article-title":"Clinical correlates and outcomes of dual basiliximab and antithymocyte globulin induction in kidney transplant recipients: a national study","volume":"7","author":"Lam","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0015","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.21037\/tau.2018.10.14","article-title":"Cytomegalovirus infection in kidney allografts: a review of literature","volume":"8","author":"Morgantetti","year":"2019","journal-title":"Transl Adrol Urol"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0016","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/tid.12998","article-title":"Native kidney cytomegalovirus nephritis and cytomegalovirus prostatitis in a kidney transplant recipient","volume":"21","author":"Tan","year":"2019","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2279-042X.200983","article-title":"Cytopenia occurrence in kidney transplant recipients within early post-transplant period","volume":"6","author":"Jafari","year":"2017","journal-title":"J Res Phar Pract"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9429265","article-title":"Drug-induced hematological cytopenia in kidney transplantation and the challenges it poses for kidney transplant physicians","volume":"2018","author":"Khalil","year":"2018","journal-title":"J Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0019","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1600-6143.2009.02699.x","article-title":"Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study","volume":"9","author":"Zafrani","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.02.067_bib0020","article-title":"Very early cytomegalovirus infection after renal transplantation: a single-center 20-year perspective","volume":"10","author":"Jorgenson","year":"2019","journal-title":"Virology (Auckl)"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:14Z","timestamp":1758577514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0041134523003998"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.02.067","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.02.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}